VEEVA SYSTEMS INC-CLASS A
VEEVNYSETrading Snapshot
- Day Range
- $272.80 β $278.69
- 52-Week Range
- $148.05 β $310.50
- Volume
- $2.22B
- Avg Volume
- $2.86B
- Shares Outstanding
- 162.4M
- Next Earnings
- Dec 15, 2026
Fundamentals Snapshot
- Annual Revenue
- $3.20B
- Last Q Revenue
- $928M
- P/E Ratio
- 45.2
- P/S Ratio
- 13.2x
- EPS (TTM)
- $6.25
- Dividend Yield
- 0.00%
- Dilution (1yr)
- β1.7%
Why Investors Own VEEV
- βHigh-growth profile β revenue up +25.3% YoY with expanding US Equity exposure.
- βHealthy economics β 50% gross margin and 23% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
VEEVA SYSTEMS INC-CLASS A
VEEVAbout VEEVA SYSTEMS INC-CLASS A
Veeva Systems Inc. is a leading provider of cloud-based software solutions, exclusively dedicated to the global life sciences industry. Its extensive operational presence spans across North America, Europe, the Asia Pacific region, the Middle East, Africa, and Latin America. The company's product portfolio is primarily structured around two major offerings. First, the Veeva Commercial Cloud delivers an integrated suite of software, data, and analytics tools designed to optimize commercial operations. This includes vital applications such as Veeva Customer Relationship Management (CRM) and its specialized Medical CRM, Veeva Closed Loop Marketing (CLM), sophisticated analytics via Veeva CRM MyInsights, approved email communication with Veeva CRM Approved Email, digital engagement tools like Veeva CRM Engage, commercial alignment through Veeva Align, event management capabilities with Veeva CRM Events Management, data warehousing solutions (Veeva Nitro), data services (Veeva OpenData, Veeva Link), master data management (Veeva Network), advanced analytical insights (Veeva Crossix, Veeva Data Cloud), and patient engagement platforms (MyVeeva for Patients). Secondly, Veeva Vault provides a robust collection of cloud-native enterprise content and data management applications. These applications are engineered to support both critical commercial functionsβencompassing sales, marketing, and medical content and communicationsβand comprehensive research and development processes, including clinical trials, regulatory compliance, quality management, and patient safety. Beyond its software, Veeva offers a wide array of professional and support services. These range from strategic implementation and deployment planning, project management, and detailed requirements analysis to solution design and configuration. They also include system environment management and deployment, expert consulting for business process transformation related to Veeva solutions, technical guidance on data migration and systems integrations, comprehensive training programs, and ongoing managed services such as outsourced systems administration. Tracing its origins, the company was incorporated in 2007 as Verticals onDemand, Inc., and subsequently rebranded to Veeva Systems Inc. in April 2009. Its corporate headquarters are situated in Pleasanton, California.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Price Target
βLatest News & Updates
Brokers Suggest Investing in Veeva (VEEV): Read This Before Placing a Bet
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their r

Veeva Systems (VEEV) Outperforms Broader Market: What You Need to Know
Veeva Systems (VEEV) closed the most recent trading day at $280.68, moving +2.12% from the previous trading session.

Veeva Unveils AI Study Builder Agent to Speed Clinical Trial Setup
VEEV's AI-powered Study Builder Agent automates clinical study setup, cutting manual work while strengthening its connected Clinical Data ecosystem.

Veeva (VEEV) Down 2.6% Since Last Earnings Report: Can It Rebound?
Veeva (VEEV) reported earnings 30 days ago. What's next for the stock?

EXCLUSIVE: AI Has A Blind Spot, Here Are 3 Overlooked Stocks
The AI trade has trained investors to look for the next Nvidia Corp (NASDAQ:NVDA), the next chip winner or the next company selling picks and shovels to data centers. But Allen Bond, Managing Director and Portfolio Manag

New Veeva Study Builder Agent to Configure Clinical Studies in as Little as One Day
Standards-first agent delivers faster and more consistent EDC and DQS builds PLEASANTON, Calif., Sept. 24, 2026 /PRNewswire/ -- Veeva SystemsΒ (NYSE: VEEV) today announced Veeva Study Builder Agent, a new AI solution that